CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO

Cerilliant Divests of Austin Pharma Subsidiary

ROUND ROCK, TX – (September 30, 2009) – Cerilliant Corporation announces the divesture of their subsidiary Austin Pharma. Austin Pharma which specializes in the manufacture of active pharmaceutical ingredients is now owned by Insys Therapeutics, headquartered in Phoenix, AZ, http://www.insystherapeutics.com/. Under the agreement with Insys Therapeutics, Austin Pharma will sublease manufacturing space from Cerilliant. According to Cerilliant CEO Sherri Pogue, “the divesture of Austin Pharma allows us to focus on our core business -- producing high quality certified reference materials, certified solution based standards and certified spiking solutions as well providing complimentary services such as packaging, analytical services, and inventory management solutions for our core markets.”

return to newsroom

© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn